Safety after extended repeated use of ulipristal acetate for uterine fibroids-Reference-Cited by-同舟云学术

Safety after extended repeated use of ulipristal acetate for uterine fibroids

Published:2017-03-07 Issue:3 Volume:12 Page:e0173523
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fauser Bart C. J. M.,Donnez Jacques,Bouchard Philippe,Barlow David H.,Vázquez Francisco,Arriagada Pablo,Skouby Sven O.,Palacios Santiago,Tomaszewski Janusz,Lemieszczuk Boguslaw,William Alistair R. W.

Funder

Gedeon Richter/PregLem S.A. Geneva, Switzerland

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference11 articles.

1. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety;P Bouchard;Fertility and sterility,2011

2. The potential of selective progesterone receptor modulators for the treatment of uterine fibroids;E Bestel;Expert review of endocrinology & metabolism,2014

3. Ulipristal acetate versus placebo for fibroid treatment before surgery;J Donnez;The New England journal of medicine,2012

4. Ulipristal acetate versus leuprolide acetate for uterine fibroids;J Donnez;The New England journal of medicine,2012

5. The spectrum of endometrial pathology induced by progesterone receptor modulators;GL Mutter;Modern Pathology,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study;Efficacy and Mechanism Evaluation;2023-10

2. The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review;Journal of Clinical Medicine;2023-09-22

3. Contemporary approaches in the management of uterine leiomyomas;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-08

4. Tratamiento médico de los miomas uterinos. Del presente al futuro;Clínica e Investigación en Ginecología y Obstetricia;2023-04

5. Medical Treatment of Adenomyosis;Current Obstetrics and Gynecology Reports;2022-03-01